Metabolic imaging with hyperpolarized 13C pyruvate magnetic resonance imaging in patients with renal tumors—Initial experience is a research paper published in Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 57 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P41EB013598
National Institutes of Health
Grant: U01EB026412
NCI NIH HHS
Grant: R01 CA249909
Research Scholar Grant from the American Cancer Society
Grant: 131715-RSG-18-005-01-CCE
National Institutes of Health
Grant: 5P41EB013598-07
Hyperpolarized MRI Technology Resource Center
National Institutes of Health
Grant: 3U01EB026412-03S1
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods
FWCI
5.87
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Hyperpolarized [1-13C]-pyruvate MRS evaluates immune potential and predicts response to radiotherapy in cervical cancer
Additional file 1 of Hyperpolarized [1-13C]-pyruvate MRS evaluates immune potential and predicts response to radiotherapy in cervical cancer